Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Showcase showdown: KC Chamber rallies ‘Mr. K competitors, but small biz owners say it feels more like family
The husband-wife duo behind Kansas City-based Shark OFF appreciate the local entrepreneurial ecosystem so much that they actually list it as one of their startup’s co-founders, Geoff Geist shared. “We would not exist if it weren’t for this community,” said Geist, the co-founder and COO of Shark OFF, which offers shark repellent bracelets that are…
Meet the winners of KC’s first grants for micro-businesses; $55K awarded to women of color
A newly launched collaboration between entrepreneur support efforts announced Thursday its first batch of grant winners — positioning four Kansas City micro-businesses for greater success amid a near-universally challenging start for the year. “The first quarter of the year is hard for most businesses, and extremely hard for small businesses. This year was no different…
These ‘Urban Heroes’ are helping evolve downtown KC; here’s why they’re on the right path
In a prelude to today’s celebration of downtown Kansas City’s evolution and momentum, four “urban heroes” were honored Thursday for their passionate work to make downtown a more vibrant place to live, work, and play, organizers said. Winners of the “Urban Hero Awards” ranged from honorees on the east side to the Crossroads and the…
Honey bunches of joy: How this Raytown bee farm landed its blooming business model
Editor’s note: This story was originally published by Kansas City PBS/Flatland, a member of the Kansas City Media Collective, which also includes Startland News, KCUR 89.3, American Public Square, The Kansas City Beacon, and Missouri Business Alert. Click here to read the original story. Erik and Rachael Messner’s home on an acre in south Kansas City gave…